Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus.
The case of a 40 year old female patient of SLE who developed fatal neuroleptic malignant syndrome following administration of serenase (haloperidol) is reported. Relevant literature has been reviewed.
Sule
A
A
Division of Medicine and Rheumatology, PD Hinduja Hospital and Medical Research Centre, Mumbai.
Gohar
S
S
Mittal
G
G
Balakrishnan
C
C
Mangat
G
G
Joshi
V R
VR
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*
D018726:Anti-Dyskinesia Agents; D006220:Haloperidol